title: Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia.
authors.affiliation: Department of Perinatology, National Center for Child Health and Development, Tokyo, Japan. yamaguchi-k@ncchd.go.jp
authors.forename: Koushi
authors.initials: K
authors.lastname: Yamaguchi
authors.forename: Michi
authors.initials: M
authors.lastname: Hisano
authors.forename: Mariko
authors.initials: M
authors.lastname: Sakata
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Minatogawa
authors.forename: Teruaki
authors.initials: T
authors.lastname: Suzuki
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Ozawa
authors.forename: Michihiro
authors.initials: M
authors.lastname: Kitagawa
authors.forename: Atsuko
authors.initials: A
authors.lastname: Murashima
mesh_terms: D000022:Abortion, Spontaneous / Q000517:prevention & control; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001783:Blood Flow Velocity; D002585:Cesarean Section; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D002546:Ischemic Attack, Transient / Q000209:etiology; D010146:Pain / Q000209:etiology; D010983:Plateletpheresis; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D018566:Pregnancy, High-Risk / Q000097:blood*; D013920:Thrombocythemia, Essential / Q000150:complications / Q000628:therapy*
chemical_list: D000925:Anticoagulants; D001241:Aspirin